Section one: Contracting authority/entity
one.1) Name and addresses
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw
Cardiff
CF15 7QZ
nwssp.procurementcataloguepathology@wales.nhs.uk
Telephone
+44 1443848585
Country
United Kingdom
NUTS code
UK - United Kingdom
Internet address(es)
Main address
http://nwssp.nhs.wales/ourservices/procurement-services/
Buyer's address
https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
CLI-VEA-57525 BREAST CANCER ARTIFICIAL INTELLIGENCE
Reference number
CLI-VEA-57525
two.1.2) Main CPV code
- 48000000 - Software package and information systems
two.1.3) Type of contract
Supplies
two.1.4) Short description
Utilising AI to support Pathologists in assessing and quantitating tumour markers when reporting breast cancer biopsies.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £167,447.96
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKL - Wales
two.2.4) Description of the procurement
Utilising AI to support Pathologists in assessing and quantitating tumour markers when reporting breast cancer biopsies.
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The procurement falls outside the scope of application of the regulations
Explanation:
A successful pilot in BCUHB is utilising AI to support Pathologists in assessing and quantitating tumour markers when reporting breast cancer biopsies. It is proposed to utilise additional funding awarded from Welsh Government to roll out this development to all Health Boards.
All Health Boards in Wales utilise Ibex for prostate biopsies, and it is also already used in BCUHB for breast biopsies. The infrastructure is in place within NHS Wales to use this system, including an existing Data Protection Impact Assessment. Due to the time constraints of the funding it is not feasible to roll out the use of a different supplier at this time.
For the reasons outlined above and to ensure the success of the project, NHS Wales have no option but to enter in to an agreement without any formal underpinning Framework Agreement for a 12 month period.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
Section five. Award of contract/concession
Contract No
CLI-VEA-57525
A contract/lot is awarded: Yes
five.2) Award of contract/concession
five.2.1) Date of conclusion of the contract
16 October 2024
five.2.2) Information about tenders
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor/concessionaire
Ibex Medical Analytics Ltd
Mixer House, 101 Rokach Blvd
Tel Aviv-Yafo
6153101
Telephone
+44 7492998884
Country
Israel
NUTS code
- IL - Israel
The contractor/concessionaire is an SME
Yes
five.2.4) Information on value of contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession: £163,447.96
Section six. Complementary information
six.3) Additional information
(WA Ref:145296)
six.4) Procedures for review
six.4.1) Review body
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
Telephone
+44 2079477501
Country
United Kingdom